In 2003, an International Think Tank on Reducing Health Disparities was held in Ottawa, Canada; it included representatives from Australia, Canada, Mexico, New Zealand, and the United States of America. The participants at that event identified individuals with disabilities (and intellectual and developmental disabilities (IDD) specifically) as one of 11 vulnerable populations with regards to being "more likely to become ill and less likely to receive appropriate care" ([@B1]). Individuals with IDD present with cognitive deficits associated with limitations in activities of daily living that begin in the developmental period, typically before the age of 18 years. As a group, they are at greater risk for health problems and for using resource-intensive health care services. However, because of their disabilities, they have greater difficulty negotiating their way through health services ([@B2]), which are often delivered through a fragmented system.

Access to primary health care for this marginalized IDD population is of strong relevance to the Declaration of Alma-Ata (1979), which highlighted the need to address health and social inequalities and to promote social justice among citizens. Preventive health services are a key aspect of primary health care ([@B3]), yet most individuals with IDD are missing out on these opportunities for health promotion and disease detection, which have the potential to greatly reduce health care disparities among individuals with IDD and those without. There is recognition of the need for health promotion for people with disabilities in the Americas ([@B4], [@B5]). In the United States, research focusing on preventive health for individuals with IDD across the lifespan is being conducted ([@B6]). However, in Latin American countries, explicit strategies are lacking to address the specific health-related needs of individuals with IDD, including for primary care ([@B7]).

The periodic health examination provides an opportunity for primary care providers to ensure preventive care and undertake earlier disease detection. It is the time when health issues that are not addressed during other appointments can be discussed. The evidence specific to adults with IDD suggests that without a dedicated approach to health assessment, inadequate care will result ([@B8]). A 2006 Welsh study revealed the ability of such a health assessment to identify previously undiagnosed health problems among adults with IDD ([@B9]). Subsequently, a cluster randomized trial in Australia demonstrated that structured comprehensive health assessments (which included a review of patient medical history, focused physical examination, and development of a health action plan) for adults with IDD led to the early identification of health issues and the prevention of more complex difficulties ([@B10]).

In light of the international literature in support of the periodic health examination for adults with IDD, in 2006, Australia and Wales instituted specific funding to physicians as an incentive to perform annual health assessments for this patient group ([@B11], [@B12]). When combined with notifications of the importance of the examination being sent to adults with IDD and their caregivers, this incentive resulted in the uptake of the annual health assessment in this population increasing from 31% in 2006/2007 to 41% in 2008/2009 ([@B12]). The practice incentive was extended across the United Kingdom in 2009 ([@B13]). A similar increase in the uptake of health checks among adults with IDD was then seen in England, from 30.5% in 2010 to 41.7% in 2011 ([@B14]). There is a need to understand diverse strategies to improve the uptake of preventive care in different jurisdictional contexts.

Context for the study
=====================

Despite Canada\'s universal access to health care, few adults with or without IDD have a periodic health examination. Although there continues to be debate in Canada and elsewhere about the utility of the periodic health examination for all patients ([@B15], [@B16]), in Ontario (which is Canada\'s most populous province), the rate of uptake from 1 April 2009 to 31 March 2011 (fiscal year (FY) 2009 and FY 2010) was 22.0% for adults with IDD, as compared to 26.4% in the general population ([@B17]). Among the oldest group studied (55 to 64 years old), the disparity was greatest, with only 24.2% of those with IDD having had a periodic health exam, compared to 31.0% of those without IDD ([@B18]). Research in Ontario has also shown that women with IDD are significantly less likely to undergo recommended cervical and breast cancer screening than are women without IDD ([@B19]). This underscores the importance of promoting preventive care, including the periodic health examination, in the IDD population.

Canadian provinces have not created financial incentives targeting the periodic health examination for adults with IDD. However, practice guidelines that include the recommendation to perform annual health assessments for these patients have been developed and disseminated to all members of the College of Family Physicians of Canada (first in 2006 ([@B20]), and then in 2011, with a package of clinical tools ([@B21])). In 2011, the Ontario government ministry responsible for policy in the area of IDD created 10 new positions to facilitate access to appropriate health care for adults with IDD. A key function of these health care facilitators has been to prepare and support their respective communities (primary care providers and IDD service agencies) to increase the adoption of the Canadian guidelines for the primary care of adults with IDD.

While primary care providers have received extensive education and outreach, our health care system requires self-referral for health assessments. Thus, engaging patients in the change process is also important. Despite the evidence that patient and caregiver empowerment approaches can increase preventive care in adults with IDD ([@B10], [@B22]), these groups were only targeted in Ontario in 2014 through a population-level health communication intervention to empower adults with IDD to access recommended preventive care. In October 2014, a large segment of the population of adults with IDD (of which 56.4% were 40 years and over) was sent a letter about the initiative, a document with images explaining the importance of the annual health exam and how to book an appointment with one\'s physician for the exam, an information sheet about the project that could be given to their physician, and an invitation to contact researchers to be included in a follow-up telephone survey ([@B23]). While the envelope was addressed to the adult with IDD, where the individual did not have the ability to read, it was to be opened, read, and explained by a caregiver.

The objective of this study was to examine the impact of the efforts described above to improve the provision of preventive care to adults with IDD 40 to 64 years of age through primary care in Ontario, Canada. The efforts include the 2006 publication of consensus guidelines, the 2011 publication of revised guidelines, tool dissemination and introduction of health care facilitators, and the 2014 health communication intervention targeting adults with IDD in Ontario.

MATERIALS AND METHODS
=====================

We used a population-based longitudinal ecological design and routinely collected health administrative data. The study relied on a previously identified cohort of adults with IDD who were 18 to 64 years of age and living in Ontario in FY 2009 ([@B24]). For each year between FY 2003 and FY 2016, subgroups of noninstitutionalized individuals who were between 40 and 64 years old and living in the province were identified. The study was restricted to noninstitutionalized persons 40 to 64 years old since the preventive care measures of interest target this group. A comparison group of the remaining Ontario population was used to control for any secular trend. Initially, the comparison group was matched on sex in order to decrease the potential number of matches, and then matched on propensity score. The propensity score was calculated using age, sex, morbidity (number of Aggregated Diagnosis Groups (ADGs) from the Johns Hopkins ACG System Version 10), neighborhood income quintile, and rurality (from the 2008 Rurality Index of Ontario (RIO) ([@B25])). A new propensity score--matched comparison group was created for each fiscal year (1 April to 31 March) to ensure the continued similarity of the groups over time. A one-to-one matching ratio, with a 0.2 caliper, was used.

Seven data sets held at the Institute for Clinical Evaluative Sciences (ICES) were used: 1) Ontario Diabetes Database (ODD); 2) Ontario Cancer Registry (OCR); 3) Ontario Health Insurance Plan (OHIP); 4) Discharge Abstract Database (DAD); 5) Same Day Surgery (SDS); 6) National Ambulatory Care Reporting System (NACRS); and 7) Registered Persons Database (RPDB) (for details about each of the data sets, see: <https://datadictionary.ices.on.ca/Applications/DataDictionary/Default.aspx>). The ICES Data Repository consists of individual-level health service records for much of Ontario\'s publicly funded system. All data sets held at ICES are anonymized and linkable through unique encoded identifiers. All analyses were conducted at ICES using SAS version 9.4 software (SAS Institute, Cary, North Carolina, United States).

A composite indicator of preventive care provision through primary care was used to measure the impact of the efforts to improve primary care provision. The composite indicator consisted of either a billing code indicative of a periodic health examination (PHE) or a value of 0.6 or greater on the Primary Care Quality Score (PCQS). The use of a composite indicator was deemed desirable due to anomalous physician billing practices and the lack of access to data related to screening tests completed in hospital or private lab settings. Previous work has demonstrated that the composite indicator identifies up 5% more adults with IDD over the age of 40 as having received recommended preventive care, as compared to using either a value of 0.6 or greater on the PCQS or PHE billing codes alone ([@B26]). As such, combining the two indicators reduces the risk of underestimating the outcome.

Periodic health exam
--------------------

The periodic health exam was defined using Ontario Health Insurance Plan (OHIP) fee code A003 with diagnostic code 917 (apparently healthy adults) or 319 (adults with IDD). Starting 1 January 2013, the fee code for the health exam for apparently healthy adults was changed to K131. If an individual received either A003 with diagnostic code 917 or 319 or fee code K131 between 1 April and 31 March of the given year (the fiscal year), they were considered to have had a health exam.

Primary Care Quality Score
--------------------------

The Primary Care Quality Score (PCQS) was first presented by Dahrouge and colleagues at the 2015 North American Primary Care Research Group conference and later revised as Preventive Care and Chronic Disease Management Performance Indicators ([@B27]). To calculate the PCQS for an individual, various administrative health data sets held at ICES were used to code all eligible preventive care measures listed in [Table 1](#t1){ref-type="table"} as either up to date or not. For example, a 50-year-old male would be considered up to date with lipid screening if he had had a lipid test that year or within the previous five years. He would *not* be considered up to date with his glucose screening if it had been four years since his last glucose test. The PCQS was categorized as high or low; a high PCQS was a score ≥ 0.6. In order to achieve a high PCQS, an individual would have had to have a minimum of two of their eligible preventive care measures up to date, including at least one cancer screening or both of the applicable blood tests (lipid and glucose for nondiabetics; lipid and hemoglobin A1c for diabetics) ([@B28]).

###### Seven guideline-recommended preventive care measures included in the calculation of the Primary Care Quality Score, according to sex and group (diabetic vs. nondiabetic), with age eligibility criteria and ineligibility where applicable

  Preventive care measure/Sex/Group   Age eligibility criteria   Guidelines     Ineligibility                                                                                                                                                                                 
  ----------------------------------- -------------------------- -------------- ---------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------- -----------------------------------
  Lipid screening                                                                                                                                                                                                                                                             
                                      Men                                                                                                                                                                                                                                     
                                                                 Diabetic       \> 40 years                                                                                                Blood level every 2 years                                                          NA[a](#TFN1){ref-type="table-fn"}
                                                                 Nondiabetic    \> 40 years                                                                                                Blood level every 5 years                                                          NA
                                      Women                                                                                                                                                                                                                                   
                                                                 Diabetic       \> 40 years                                                                                                Blood level every 2 years                                                          NA
                                                                 Nondiabetic    \> 50 years                                                                                                Blood level every 5 years                                                          NA
  Glucose screening                                                                                                                                                                                                                                                           
                                      Men & women                                                                                                                                                                                                                             
                                                                 Nondiabetic    \> 40 years                                                                                                Blood level every 3 years                                                          NA
  Cervical cancer screening                                                                                                                                                                                                                                                   
                                      Women                      20--69 years   Pap[b](#TFN2){ref-type="table-fn"} test every 3 years                                                      Previous diagnosis of cervical, ovarian, and endometrial cancer, or hysterectomy   
  Breast cancer screening                                                                                                                                                                                                                                                     
                                      Women                      50--69 years   Mammography every 2 years                                                                                  Previous diagnosis of breast cancer                                                
  Colorectal cancer screening                                                                                                                                                                                                                                                 
                                      Men & women                50--74 years   FOBT[c](#TFN3){ref-type="table-fn"} every 2 yearsSigmoidoscopy, every 5 yearsColonoscopy, every 10 years   Previous diagnosis of colorectal cancer, or colectomy or colorectal exclusion      
  Eye exam                                                                                                                                                                                                                                                                    
                                      Men & women                                                                                                                                                                                                                             
                                                                 Diabetic       \> 40 years                                                                                                Two tests every 2 years                                                            NA
  Hemoglobin A1c screening                                                                                                                                                                                                                                                    
                                      Men & women                                                                                                                                                                                                                             
                                                                 Diabetic       \> 40 years                                                                                                Four blood tests every 2 years                                                     NA

Source:

Prepared by the authors, based on a paper by Dahrouge and colleagues (
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).

NA = not applicable.

Pap = Papanicolaou.

FOBT = fecal occult blood test.

Standardized difference was used to assess the matching balance between groups (IDD vs. non-IDD, and IDD who were sent the health communication by mail ("mail-out" group) vs. those with IDD who were not sent the information ("no mail-out" group)). The crude and age-adjusted percentage of adults who received a high PCQS or a periodic health exam was plotted to assess the historical trends; all age-adjusted percentages were stratified by sex. To assess the impact of efforts, two-year percentages were averaged and then rate ratios were calculated to determine if there were within-group or between-group differences over time. To reveal the impact of the 2014 population-based health communication intervention, the results were stratified by intervention group (mail-out vs. no mail-out). The binomial distribution was used to calculate the 95% confidence intervals (CIs).

The study was approved by the Queen\'s University Health Sciences and Affiliated Hospitals Research Ethics Board, the University of Ottawa\'s Research Ethics Board, and the Research Ethics Board at Sunnybrook Health Sciences Centre, Toronto, Canada. All analyses were conducted at ICES, which has a special designation under Ontario\'s Personal Health Information Protection Act allowing it to collect and use data under strict privacy practices.

RESULTS
=======

The subgroups of adults with IDD ranged in size from 20 030 in 2003 to 28 080 in 2016 as, year by year, more individuals were added to the subgroup (reached age 40) than were removed (reached age 65 or died). When data are presented, the year given in always the fiscal year (FY). A fiscal year is from 1 April of the year named to 31 March of the subsequent year. For example, FY 2003 is 1 April 2003 to 31 March 2004. As shown in Table 2, in 2009 (the initial cohort creation year), the average age of adults with IDD was 50.1 years and 54.1% of subgroup members with IDD were men. On average, they had a moderate illness burden (2.1 ADGs) ([@B29]). They were more likely to live in low-income neighborhoods and in urban centers (RIO 0-39 is considered urban ([@B30])). With the exception of increasing mean age and slight fluctuations in ADGs over time, the IDD subgroup characteristics remained stable over the observation period. [Table 2](#t2){ref-type="table"} also shows that the matching was successful, resulting in no significant differences in IDD and non-IDD subgroups in each year by matching variables. The standardized differences for 2003, 2009, and 2016 are all 0.01 or smaller.

###### Cohort balance across matching variables for adults aged 40 to 64 with intellectual and developmental disabilities (IDD) and without intellectual and developmental disabilities (non-IDD) in fiscal years 2003, 2009, and 2016 in Ontario, Canada

  Characteristics                                          2003            2009             2016                                                                                                            
  -------------------------------------------------------- --------------- ---------------- --------------- --------------- --------------- --------------- --------------- --------------- --------------- ---------
  Age (years) (mean ± SD)[b](#TFN5){ref-type="table-fn"}   47.39 ± 5.22    46.36 ± 5.21     0.01            50.13 ± 6.54    50.11 ± 6.53    \< 0.01         51.46 ± 6.77    51.46 ± 6.76    \< 0.01         
  Sex (no. and %)                                                                                                                                                                                           
                                                           Female          9 106(45.6%)     9 173(45.8%)    \< 0.01         12 378(45.5%)   12 595(45.9%)   0.01            12 641(45.3%)   12 753(45.4%)   \< 0.01
                                                           Male            10 855 (54.4%)   10 857(54.2%)   \< 0.01         14 798(54.5%)   14 873(54.1%)   0.01            15 269(54.7%)   15 327(54.6%)   \< 0.01
  ADGs[c](#TFN6){ref-type="table-fn"} (mean ± SD)          1.93 ± 2.84     1.95± 2.81       0.01            1.95 ± 2.75     2.04 ± 2.87     0.03            2.10 ± 2.96     2.17 ± 3.07     0.02            
  Income quintile (no. and %)                                                                                                                                                                               
                                                           1 - lowest      6 849(34.3%)     6 780(33.8%)    0.01            9 187(33.8%)    9 131(33.2%)    0.01            9 193(32.9%)    9 119(32.5%)    0.01
                                                           2               4 460(22.3%)     4 450(22.2%)    \< 0.01         5 978(22.0%)    6 010(21.9%)    \< 0.01         6 058(21.7%)    6 109(21.8%)    \< 0.01
                                                           3               3 353(16.8%)     3 382(16.9%)    \< 0.01         4 605(16.9%)    4 734(17.2%)    0.01            4 887(17.5%)    4 893(17.4%)    \< 0.01
                                                           4               2 927(14.7%)     3 002(15.0%)    0.01            4 094(15.1%)    4 181(15.2%)    \< 0.01         4 331(15.5%)    4 429(15.8%)    0.01
                                                           5 - highest     2 372(11.9%)     2 416(12.1%)    0.01            3 312(12.2%)    3 412(12.4%)    0.01            3 441(12.3%)    3 530(12.6%)    0.01
  Rurality (mean ± SD)                                     15.29 ± 19.94   15.43 ± 19.96    0.01            14.81 ± 19.78   14.98 ± 19.80   0.01            14.00 ± 19.10   14.11 ± 19.20   0.01            

Source:

Prepared by the authors, based on the study results.

St diff = standardized difference.

SD = standard deviation.

ADGs = Aggregated Diagnosis Groups.

[Figure 1](#f1){ref-type="fig"} depicts the time trend (2003 to 2015) for the composite outcome (PHE or PCQS ≥ 0.6) for IDD and non-IDD subgroups. An increase in the percentage with IDD meeting criteria for the composite outcome was observed over time, from 43.4% in 2003 to 55.7% in 2015. A comparable increase was observed in the non-IDD subgroups but only until 2011. After that, the percentage declined to 57.4% in 2015, resulting in a narrowing of the gap between IDD and non-IDD subgroups.

![Crude percentage of adults aged 40--64 years old with intellectual and developmental disabilities (IDD) and without intellectual and developmental disabilities (non-IDD) receiving a periodic health exam or scoring 0.6 or greater on the Primary Care Quality Score each fiscal year (1 April to 31 March) from 2003 to 2015 in Ontario, Canada](rpsp-42-e154-g001){#f1}

Age-adjusting and stratifying the outcome by sex reveals that the narrowing of the gap due to sustained improvements after 2010 is seen only in men with IDD ([Figure 2](#f2){ref-type="fig"}). Over the 13-year period, after adjusting for age, a 53.7% increase in the outcome was seen in men with IDD (39.3% to 60.4%), compared to only 31.4% in men without IDD (41.3% to 54.3%). For the two groups of women, however, after adjusting for age, the percent increases from 2003 to 2015 were more similar (30.9% for those with IDD, 23.0% for those without IDD) ([Figure 3](#f3){ref-type="fig"}). The persisting gap seen in women is due in part to the disparity between the two groups of women with regards to the outcome in 2003, when only 37.0% of women with IDD met the criteria for the composite outcome, compared to 47.5% of women without IDD.
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[Table 3](#t3){ref-type="table"} provides two-fiscal-year average percentages for the composite outcome stratified by sex for IDD and non-IDD subgroups. According to the time trends analysis, the improvement is only seen in males with IDD. Rate ratios comparing the percentages of all IDD subgroup members in subsequent years who met the criteria for the composite outcome in relation to previous years reveal a gradual modest increase in males (e.g., rate ratio of 1.04 when comparing 2015 and 2016 to 2009 and 2010), but a decline in women (e.g., rate ratio of 0.95 when comparing 2013 and 2014 or 2015 and 2016 to 2009 and 2010) ([Table 3](#t3){ref-type="table"}).

###### Comparison of two-fiscal-year average percentages of adults aged 40 to 64 years with intellectual and developmental disabilities (IDD) and without intellectual and developmental disabilities (IDD) who received a score of 0.6 or greater on the Primary Care Quality Score (PCQS) and/or a periodic health exam (PHE) from 1 April 2009 to 31 March 2017 in Ontario, Canada, stratified by sex

  Sex/Fiscal year[a](#TFN7){ref-type="table-fn"}   Average percentage (95% confidence interval)   IDD rate ratio (95% confidence interval)                                                                                  
  ------------------------------------------------ ---------------------------------------------- ------------------------------------------ ---------------------- ----------------------------------- ------------------- -------------------
  Male                                                                                                                                                                                                                      
                                                   2009 & 2010                                    58.31 (57.75--58.87)                       54.34 (53.78--54.90)   NA[b](#TFN8){ref-type="table-fn"}   NA                  NA
                                                   2011 & 2012                                    59.10 (58.55--59.66)                       55.16 (54.61--55.72)   1.01 (1.00--1.03)                   NA                  NA
                                                   2013 & 2014                                    58.93 (58.38--59.49)                       53.24 (52.68--53.80)   1.01 (1.00--1.02)                   1.00 (0.98--1.01)   NA
                                                   2015 & 2016                                    60.42 (59.63--61.21)                       54.34 (53.54--55.14)   1.04 (1.02--1.05)                   1.02 (1.01--1.04)   1.03 (1.01--1.04)
  Female                                                                                                                                                                                                                    
                                                   2009 & 2010                                    50.77 (50.16--51.38)                       63.10 (62.51--63.70)   NA                                  NA                  NA
                                                   2011 & 2012                                    50.42 (49.81--51.03)                       61.79 (61.20--62.39)   0.99 (0.98--1.01)                   NA                  NA
                                                   2013 & 2014                                    48.14 (47.53--48.76)                       58.55 (57.94--59.16)   0.95 (0.93--0.97)                   0.95 (0.94--0.97)   NA
                                                   2015 & 2016                                    48.45 (47.57--49.32)                       58.42 (57.55--59.28)   0.95 (0.93--0.98)                   0.96 (0.94--0.98)   1.01 (0.98--1.03)

Source:

Prepared by the authors, based on the study results.

2015 & 2016 is average of 2015 PCQS or PHE and 2016 PHE due to data required to compute PCQS for 2016 not being available at time of analysis.

NA = not applicable.

When examining the difference over time between those who were mailed the health communication intervention in October 2014 (mail-out; n = 13 790 in 2003 to n = 19 102 in 2016) and those who were not sent the information (no mail-out; n = 6 240 in 2003 to n = 8 978 in 2016), the improvement in uptake in males only persists ([Table 4](#t4){ref-type="table"}). Following the October 2014 intervention, a small but statistically significant increase was observed among men in the mail-out group (rate ratio of 1.03 (95% CI: 1.01--1.05) when comparing 2015 and 2016 to 2013 and 2014), while no change was seen among women (rate ratio of 1.01. 95% CI: 0.99--1.04) when comparing 2015 and 2016 to 2013 and 2014) ([Table 4](#t4){ref-type="table"}).

###### Comparison of adults aged 40 to 64 years with intellectual and developmental disabilities two-fiscal-year average percentage of who received and did not receive the mail-out who received a score of 0.6 or greater on the Primary Care Quality Score (PCQS) and/or a periodic health exam (PHE) from 1 April 2009 to 31 March 2017 in Ontario, Canada, stratified by sex

  Sex/Fiscal year[a](#TFN9){ref-type="table-fn"}   Average percentage (95% confidence interval)   Mail-out rate ratio (95% confidence interval)                                                                                   
  ------------------------------------------------ ---------------------------------------------- ----------------------------------------------- ---------------------- ------------------------------------ ------------------- -------------------
  Male                                                                                                                                                                                                                            
                                                   2009 & 2010                                    57.11 (56.45--57.78)                            61.03 (60.01--62.05)   NA[b](#TFN10){ref-type="table-fn"}   NA                  NA
                                                   2011 & 2012                                    58.25 (57.59--58.91)                            61.11 (60.08--62.14)   1.02 (1.00--1.04)                    NA                  NA
                                                   2013 & 2014                                    58.69 (58.02--59.35)                            59.42 (58.38--60.45)   1.03 (1.01--1.04)                    1.01 (0.99--1.02)   NA
                                                   2015 & 2016                                    60.61 (59.67--61.55)                            59.92 (58.45--61.39)   1.06 (1.04--1.08)                    1.04 (1.02--1.06)   1.03 (1.01--1.05)
  Female                                                                                                                                                                                                                          
                                                   2009 & 2010                                    47.67 (46.91--48.42)                            56.66 (55.62--57.69)   NA                                   NA                  NA
                                                   2011 & 2012                                    47.31 (46.55--48.06)                            56.30 (55.27--57.34)   0.99 (0.97--1.02)                    NA                  NA
                                                   2013 & 2014                                    45.22 (44.46--45.97)                            53.72 (52.67--54.76)   0.95 (0.93--0.97)                    0.96 (0.93--0.98)   NA
                                                   2015 & 2016                                    45.89 (44.81--46.97)                            53.30 (51.82--54.78)   0.96 (0.94--0.99)                    0.97 (0.94--1.00)   1.01 (0.99--1.04)

Source:

Prepared by the authors, based on the study results.

2015 & 2016 is average of 2015 PCQS or PHE and 2016 PHE due to data required to compute PCQS for 2016 not being available at time of analysis.

NA = not applicable.

In summary, when comparing the two-year average percentages comparing IDD vs. non-IDD ([Table 3](#t3){ref-type="table"}) and mail-out vs. no-mail-out groups ([Table 4](#t4){ref-type="table"}), we see that the publication of guidelines, dissemination of tools, and hiring of health care facilitators in FY 2011 and the October 2014 health communication intervention had a small but statistically significant effect in increasing the percentage of men with IDD receiving a health exam or high PCQS. No effect was seen among women with IDD that could not be attributed to changes in practice regarding preventive care for women generally.

DISCUSSION
==========

Ontario\'s approach to improving primary care provision to adults with IDD since 2006 has had a marginal impact on individuals 40 to 64 years of age. The efforts have included disseminating guidelines and tools, designating regional personnel to promote the use of the guidelines, and informing adults with IDD to avail themselves of the periodic health examination. Despite these actions, in 2015, over 44% of adults with IDD who were 40 to 64 years old did not receive recommended preventive care. For this group, the efforts in Ontario to enhance preventive care have not been as successful as the incentive-based approach tested in England ([@B31]).

Our findings suggest that the efforts in Ontario may have small incremental effects, but only for men. A number of factors may have contributed to the lack of significant change in preventive care among women with IDD. One factor relates to the additional challenges inherent to female-specific cancer screening. Such challenges include obtaining valid consent for invasive procedures such as the Pap test, and addressing women\'s fear, embarrassment, and lack of understanding related to the Pap test and mammography. These barriers may not be limited to female-specific cancer screening. A study of the general population in the United Kingdom showed that women report more fear of discomfort, embarrassment, and anxiety with regard to invasive cancer screening procedures than do men ([@B32]). Though approaches have been developed to support women with IDD undergoing cancer screening, they have not been widely adopted ([@B33]).

A limitation of our study was our inability to determine how many of the adults with IDD who received the October 2014 health communication intervention (the mail-out group) were unable to access the periodic health examination. A follow-up survey to the mail-out group members revealed challenges with access. Among those who volunteered to participate in the survey (85 adults with IDD and 85 caregivers), some reported that the adult with IDD did not have a family doctor (6%), some caregivers did not deem it important for the individual with IDD to have a periodic health exam (9%), and some reported that the family doctor was not willing to perform the periodic health examination (2%) ([@B34], [@B35]). Another limitation was our reliance on health administrative data to capture information on preventive care. Such data is limited to activities for which physicians can bill the provincial health insurance plan. Important preventive care activities such as weight and blood pressure monitoring, smoking cessation, and dietary advice are not captured in the data sets available at this time.

A strength of this study was the ability to use matching to control for differences between adults with IDD and those without IDD. As such, differences seen in the quality of primary care are unlikely to be attributable to differences in sociodemographic or morbidity differences in the groups. However, it is important to note that the reported percentages for the non-IDD subgroups do not represent the non-IDD population per se but rather the experience of a sample similar to the IDD subgroups in terms of age, sex, neighborhood income, rurality, and morbidity.

Future research should consider other potential outcomes of efforts such as those examined in this study, including improvements to patient awareness and comfort in patient-physician communication. Research is also needed to document and understand the impact of initiatives to improve preventive care to younger and older individuals with IDD. In the absence of recommended and billable activities relevant to these outcomes and age groups, such studies will require different data and study designs.

Conclusions
===========

Across the province, Ontario has invested in several interconnected strategies to improve primary care provision to adults with IDD. Continued monitoring of the quality of that care is warranted to better understand the long-term impacts of the initiatives.

According to the results of our study, the dissemination of guidelines and tools to physicians or targeting adults with IDD through a mail-out had little impact on uptake of preventive care at the population level in the short term. Although sex differences have been identified, the barriers to uptake for adults with IDD remain unclear. Moving forward, it will be important to thoroughly explore the barriers to preventive care uptake for adults with IDD. A variety of new approaches to improving such care could be considered, including financial incentives and quality assurance measures targeting primary care providers, advocacy to change funding policies and practices, and continued education and empowerment of adults with IDD and their caregivers. The way forward should be informed by a strong theoretical basis and be supported by a thorough understanding of barriers. It will be important to examine how much value different strategies contribute to measured outcomes and understand how they interact to affect outcomes.
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